RxDoctor Payments Data

Molly Silas, MD

Psychiatry · Chanhassen, MNNPI 1639197502

Payments from drug & device makers

$480in general payments, 2019–2025

Across 33 payments — averaging $14.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$64
  • Neuronetics, Inc.$59
  • Alkermes, Inc.$49
  • Lundbeck LLC$47
  • Vanda Pharmaceuticals Inc.$46
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$28
  • plus $187 from 12 others

What the payments were for

  • Food & beverage$480100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$480 in reported general payments places this provider in the 85th percentile of 552 psychiatry providers in Minnesota.

See all psychiatry providers in Minnesota

Medicare billing

Part B allowed, 2024
$37,737
Medicare patients
72
Services billed
365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate24$207,296
AustedoDeutetrabenazine24$165,298
Abilify MaintenaAripiprazole13$40,577
Risperdal ConstaRisperidone Microspheres13$33,010
Invega SustennaPaliperidone Palmitate13$31,053
TrintellixVortioxetine Hydrobromide45$28,567
ProzacFluoxetine Hcl12$17,650
Lurasidone Hcl38$12,580
Clozapine178$12,318
Desvenlafaxine Succinate ErDesvenlafaxine Succinate114$7,688
Aripiprazole45$6,920
Trazodone Hcl254$5,278
Duloxetine Hcl119$5,206
Gabapentin162$4,557
Bupropion XlBupropion Hcl134$3,718

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$15$165,29824 claims
Johnson & JohnsonRisperdal Consta, Invega Sustenna$17$64,06326 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$64$28,56745 claims
Lilly USA, LLCOlanzapine$20$2,46292 claims
Almatica Pharma LLCSertraline Hcl$13$1,06681 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 552 psychiatry providers in Minnesota.

Other psychiatry in Chanhassen

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →